Multifunctional neuroprotective drugs targeting monoamine oxidase inhibition, iron chelation, adenosine receptors, and cholinergic and glutamatergic action for neurodegenerative diseases. [electronic resource]
Producer: 20071026Description: 873-86 p. digitalISSN:- 1744-7658
- Acetylcholine -- metabolism
- Adenosine A2 Receptor Antagonists
- Animals
- Apoptosis -- drug effects
- Calcium -- metabolism
- Calcium Channel Blockers -- pharmacology
- Carbamates -- pharmacology
- Cholinesterase Inhibitors -- pharmacology
- Drug Design
- Excitatory Amino Acid Antagonists -- pharmacology
- Free Radical Scavengers -- pharmacology
- Humans
- Hydroxyquinolines -- pharmacology
- Iron Chelating Agents -- pharmacology
- Monoamine Oxidase Inhibitors -- pharmacology
- Neurodegenerative Diseases -- drug therapy
- Neuroprotective Agents -- pharmacology
- Piperazines -- pharmacology
- Purines -- pharmacology
- Receptor, Adenosine A2A -- metabolism
- Receptors, N-Methyl-D-Aspartate -- antagonists & inhibitors
- Serotonin Plasma Membrane Transport Proteins -- metabolism
- Selective Serotonin Reuptake Inhibitors -- pharmacology
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.